# Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma

> **NCT01418495** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 12 (estimated)

## Conditions studied

- Localized Resectable Neuroblastoma
- Localized Unresectable Neuroblastoma
- Neurotoxicity Syndrome
- Pain
- Regional Neuroblastoma
- Stage 4 Neuroblastoma
- Stage 4S Neuroblastoma

## Interventions

- **OTHER:** Cytology Specimen Collection Procedure
- **OTHER:** Pharmacological Study

## Key facts

- **NCT ID:** NCT01418495
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-26
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2019-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01418495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01418495, "Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01418495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*